Roberta Littleford
Overview
Explore the profile of Roberta Littleford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan F, Mair F, Anderson W, Chew C, Dorward A, Haughney J, et al.
PLoS One
. 2025 Jan;
20(1):e0306163.
PMID: 39774508
The role of biomarkers in risk-based early detection of lung cancer may enable screening to become cost effective and widely accessible. EarlyCDT-Lung is an example of such a blood-based autoantibody...
2.
Slob E, Vijverberg S, Ruffles T, Noij L, Biermann J, Brouwer A, et al.
Allergy
. 2024 Dec;
PMID: 39723595
Background: Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially...
3.
Weir-McCall J, Fitton C, Gandy S, Lambert M, Littleford R, Houston J, et al.
Radiology
. 2024 Nov;
313(2):e232997.
PMID: 39499172
Background Left ventricular mass (LVM) is an established marker of cardiovascular risk; however, long-term follow-up studies in individuals with low to intermediate risk are lacking. Purpose To assess the sex-specific...
4.
Morpeth S, Venkatesh B, Totterdell J, McPhee G, Mahar R, Jones M, et al.
NEJM Evid
. 2024 Feb;
2(11):EVIDoa2300132.
PMID: 38320527
BACKGROUND: Nafamostat mesylate is a potent in vitro antiviral agent that inhibits the host transmembrane protease serine 2 enzyme used by severe acute respiratory syndrome coronavirus 2 for cell entry....
5.
Dissanayaka N, Pourzinal D, Byrne G, Yang J, McMahon K, Pontone G, et al.
Pilot Feasibility Stud
. 2023 Nov;
9(1):189.
PMID: 37993889
Background: Mild memory impairment, termed amnestic mild cognitive impairment (aMCI), is associated with rapid progression towards dementia in Parkinson's disease (PD). Studies have shown hyperactivation of hippocampal DG/CA3 subfields during...
6.
Symons T, Straiton N, Gagnon R, Littleford R, Campbell A, Bowen A, et al.
Trials
. 2022 Dec;
23(1):1055.
PMID: 36578070
Background: For decades, the research community has called for participant information sheets/consent forms (PICFs) to be improved. Recommendations include simplifying content, reducing length, presenting information in layers and using multimedia....
7.
Robertson J, Coleman R, Cheung K, Evans A, Holcombe C, Skene A, et al.
Clin Cancer Res
. 2022 Dec;
28(24):5469.
PMID: 36519303
No abstract available.
8.
Lambert M, Houston J, Littleford R, Fitton C, Struthers A, Sullivan F, et al.
BMJ Open
. 2022 Oct;
12(10):e063594.
PMID: 36270757
Purpose: Risk factor-based models struggle to accurately predict the development of cardiovascular disease (CVD) at the level of the individual. Ways of identifying people with low predicted risk who will...
9.
Stewart A, Harris P, Chatfield M, Littleford R, Paterson D
Trials
. 2021 Apr;
22(1):301.
PMID: 33888139
Background: Extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales are common causes of bloodstream infection. ESBL-producing bacteria are typically resistant to third-generation cephalosporins and result in a sizeable economic and public health...
10.
Ruffles T, Jones C, Palmer C, Turner S, Grigg J, Tavendale R, et al.
Eur Respir J
. 2021 Jan;
58(2).
PMID: 33479111
Introduction: The A allele of rs1042713 (Arg16 amino acid) in the β-adrenoreceptor is associated with poor response to long-acting β-agonist (LABA) in young people with asthma. Our aim was to...